lobbying_filings_raw: 203cfcd2-8ac1-4d8d-b618-e4f8a2ba59a5
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| filing_uuid | filing_type | registrant_id | registrant_name | client_id | client_name | filing_year | filing_period | received_date | amount_reported | is_amendment | is_no_activity | is_termination | raw_json |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 203cfcd2-8ac1-4d8d-b618-e4f8a2ba59a5 | Q1 | 286074 | PHARMAVITE LLC | 176428 | PHARMAVITE LLC | 2021 | first_quarter | 2021-04-05T14:55:32.003000-04:00 | 80000.0 | 0 | 0 | 0 | {"url": "https://lda.senate.gov/api/v1/filings/203cfcd2-8ac1-4d8d-b618-e4f8a2ba59a5/", "filing_uuid": "203cfcd2-8ac1-4d8d-b618-e4f8a2ba59a5", "filing_type": "Q1", "filing_type_display": "1st Quarter - Report", "filing_year": 2021, "filing_period": "first_quarter", "filing_period_display": "1st Quarter (Jan 1 - Mar 31)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/203cfcd2-8ac1-4d8d-b618-e4f8a2ba59a5/print/", "filing_document_content_type": "text/html", "income": null, "expenses": "80000.00", "expenses_method": "a", "expenses_method_display": "Method A - Reporting amounts using LDA definitions only", "posted_by_name": "Ingrid Lebert", "dt_posted": "2021-04-05T14:55:32.003000-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "8531 Fallbrook Ave.", "registrant_address_2": null, "registrant_different_address": false, "registrant_city": "West Hills", "registrant_state": "CA", "registrant_zip": "91304", "registrant": {"id": 286074, "url": "https://lda.senate.gov/api/v1/registrants/286074/", "house_registrant_id": 36957, "name": "PHARMAVITE LLC", "description": null, "address_1": "8531 Fallbrook Ave.", "address_2": null, "address_3": null, "address_4": null, "city": "West Hills", "state": "CA", "state_display": "California", "zip": "91304", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "INGRID LEBERT", "contact_telephone": "+1 202-492-4486", "dt_updated": "2026-03-05T12:26:01.923676-05:00"}, "client": {"id": 176428, "url": "https://lda.senate.gov/api/v1/clients/176428/", "client_id": 12, "name": "PHARMAVITE LLC", "general_description": null, "client_government_entity": false, "client_self_select": true, "state": "CA", "state_display": "California", "country": "US", "country_display": "United States of America", "ppb_state": "CA", "ppb_state_display": "California", "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2007-08-03"}, "lobbying_activities": [{"general_issue_code": "MAN", "general_issue_code_display": "Manufacturing", "description": "S.297, Reinforcing American-Made Products Act, a bill to make exclusive the authority of the Federal Government to regulate the labeling of products made in the United States and introduced in interstate or foreign commerce, and for other purposes; all provisions relating to dietary supplements.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 71867, "prefix": null, "prefix_display": null, "first_name": "INGRID", "nickname": null, "middle_name": null, "last_name": "LEBERT", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "TAX", "general_issue_code_display": "Taxation/Internal Revenue Code", "description": "S.380, Health Savings Act, a bill to amend the Internal Revenue Code of 1986 to improve access to health care through expanded health savings accounts; all provisions related to dietary supplements.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 71867, "prefix": null, "prefix_display": null, "first_name": "INGRID", "nickname": null, "middle_name": null, "last_name": "LEBERT", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "BUD", "general_issue_code_display": "Budget/Appropriations", "description": "Increase funding for the Office of Dietary Supplement Programs at FDA", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 71867, "prefix": null, "prefix_display": null, "first_name": "INGRID", "nickname": null, "middle_name": null, "last_name": "LEBERT", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "CSP", "general_issue_code_display": "Consumer Issues/Safety/Products", "description": "H.R.2013, Information Transparency & Personal Data Control Act, a bill to require the Federal Trade Commission to promulgate regulations related to sensitive personal information, and for other purposes; all provisions relating to dietary supplements.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 71867, "prefix": null, "prefix_display": null, "first_name": "INGRID", "nickname": null, "middle_name": null, "last_name": "LEBERT", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "FOO", "general_issue_code_display": "Food Industry (safety, labeling, etc.)", "description": "H.R. 841, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021, a bill to make hemp, cannabidiol derived from hemp, and any other ingredient derived from hemp lawful for use under the Federal Food, Drug, and Cosmetic Act as a dietary ingredient in a dietary supplement; all provisions relating to dietary supplements.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 71867, "prefix": null, "prefix_display": null, "first_name": "INGRID", "nickname": null, "middle_name": null, "last_name": "LEBERT", "suffix": null, "suffix_display": null}, "covered_position": null, "new": true}], "government_entities": [{"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "ENV", "general_issue_code_display": "Environment/Superfund", "description": "(Bill #TBD), Break Free from Plastic Pollution Act, a bill to amend the Solid Waste Disposal Act to reduce the production and use of certain single-use plastic products and packaging, to improve the responsibility of producers in the design, collection, reuse, recycling, and disposal of their consumer products and packaging, to prevent pollution from consumer products and packaging from entering into animal and human food chains and waterways, and for other purposes; all provisions relating to dietary supplements.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 71867, "prefix": null, "prefix_display": null, "first_name": "INGRID", "nickname": null, "middle_name": null, "last_name": "LEBERT", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} |